Granite Point Capital Management, L.P. Forte Biosciences, Inc. Transaction History

Granite Point Capital Management, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$31.5 - $42.5 $1.39 Million - $1.87 Million	-44,000 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$28.66 - $46.79 $1.26 Million - $2.06 Million	44,000 New	44,000 $1.6 Million

175K

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.